Guo H, Zhao L, Zhu J, Chen P, Wang H, Jiang M, et al. Microbes in lung cancer initiation, treatment, and outcome: Boon or bane? Semin Cancer Biol. 2022;86(Pt 2):1190–206.
Article CAS PubMed Google Scholar
Di Federico A, De Giglio A, Gelsomino F, Sperandi F, Melotti B, Ardizzoni A. Predictors of survival to immunotherapy and chemoimmunotherapy in non-small cell lung cancer: a meta-analysis. J Natl Cancer Inst. 2023;115(1):29–42.
Cella E, Zullo L, Marconi S, Rossi G, Coco S, Dellepiane C, et al. Immunotherapy-chemotherapy combinations for non-small cell lung cancer: current trends and future perspectives. Expert Opin Biol Ther. 2022;22(10):1259–73.
Article CAS PubMed Google Scholar
Lantuejoul S, Sound-Tsao M, Cooper WA, Girard N, Hirsch FR, Roden AC, et al. PD-L1 testing for Lung Cancer in 2019: perspective from the IASLC Pathology Committee. J Thorac Oncol. 2020;15(4):499–519.
Article CAS PubMed Google Scholar
Borghaei H, Langer CJ, Paz-Ares L, Rodríguez-Abreu D, Halmos B, Garassino MC, et al. Pembrolizumab plus chemotherapy versus chemotherapy alone in patients with advanced non-small cell lung cancer without tumor PD-L1 expression: a pooled analysis of 3 randomized controlled trials. Cancer. 2020;126(22):4867–77.
Article CAS PubMed Google Scholar
Munoz-Schuffenegger P, Kandel S, Alibhai Z, Hope A, Bezjak A, Sun A, et al. A Prospective Study of Magnetic Resonance Imaging Assessment of post-radiation changes following stereotactic body Radiation Therapy for Non-small Cell Lung Cancer. Clin Oncol (R Coll Radiol). 2019;31(10):720–7.
Article CAS PubMed Google Scholar
Vogl TJ, Hoppe AT, Gruber-Rouh T, Basten L, Dewes P, Hammerstingl RM, et al. Diffusion-weighted MR imaging of primary and secondary Lung Cancer: predictive value for response to Transpulmonary Chemoembolization and Transarterial Chemoperfusion. J Vasc Interv Radiol. 2020;31(2):301–10.
Jagoda P, Fleckenstein J, Sonnhoff M, Schneider G, Ruebe C, Buecker A, et al. Diffusion-weighted MRI improves response assessment after definitive radiotherapy in patients with NSCLC. Cancer Imaging. 2021;21(1):15.
Vogl TJ, Emara EH, Elhawash E, Naguib NNN, Aboelezz MO, Abdelrahman HM, et al. Feasibility of diffusion-weighted magnetic resonance imaging in evaluation of early therapeutic response after CT-guided microwave ablation of inoperable lung neoplasms. Eur Radiol. 2022;32(5):3288–96.
Article CAS PubMed Google Scholar
Iima M, Kataoka M, Kanao S, Onishi N, Kawai M, Ohashi A, et al. Intravoxel Incoherent Motion and quantitative non-gaussian diffusion MR Imaging: evaluation of the Diagnostic and Prognostic Value of several markers of malignant and benign breast lesions. Radiology. 2018;287(2):432–41.
Wan Q, Deng YS, Lei Q, Bao YY, Wang YZ, Zhou JX, et al. Differentiating between malignant and benign solid solitary pulmonary lesions: are intravoxel incoherent motion and diffusion kurtosis imaging superior to conventional diffusion-weighted imaging? Eur Radiol. 2019;29(3):1607–15.
Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology. 1988;168(2):497–505.
Wan Q, Bao Y, Xia X, Liu J, Wang P, Peng Y, et al. Intravoxel Incoherent Motion Diffusion-Weighted Imaging for Predicting and Monitoring the response of anti-angiogenic treatment in the Orthotopic Nude Mouse Model of Lung Adenocarcinoma. J Magn Reson Imaging. 2022;55(4):1202–10.
Karayama M, Yoshizawa N, Sugiyama M, Mori K, Yasui H, Hozumi H, et al. Intravoxel incoherent motion magnetic resonance imaging for predicting the long-term efficacy of immune checkpoint inhibitors in patients with non-small-cell lung cancer. Lung Cancer. 2020;143:47–54.
Huang C, Liang J, Ma M, Cheng Q, Xu X, Zhang D, et al. Evaluating the treatment efficacy of Nano-Drug in a Lung Cancer Model using Advanced Functional magnetic resonance imaging. Front Oncol. 2020;10:563932.
Article PubMed PubMed Central Google Scholar
Rosenkrantz AB, Padhani AR, Chenevert TL, Koh DM, De Keyzer F, Taouli B, et al. Body diffusion kurtosis imaging: basic principles, applications, and considerations for clinical practice. J Magn Reson Imaging. 2015;42(5):1190–202.
Yuan M, Pu XH, Xu XQ, Zhang YD, Zhong Y, Li H, et al. Lung adenocarcinoma: Assessment of epidermal growth factor receptor mutation status based on extended models of diffusion-weighted image. J Magn Reson Imaging. 2017;46(1):281–9.
Feng P, Shao Z, Dong B, Fang T, Huang Z, Li Z, et al. Application of diffusion kurtosis imaging and (18)F-FDG PET in evaluating the subtype, stage and proliferation status of non-small cell lung cancer. Front Oncol. 2022;12:989131.
Article CAS PubMed PubMed Central Google Scholar
Bao X, Bian D, Yang X, Wang Z, Shang M, Jiang G, et al. Multiparametric MRI for evaluation of pathological response to the neoadjuvant chemo-immunotherapy in resectable non-small-cell lung cancer. Eur Radiol. 2023;33(12):9182–93.
Article CAS PubMed Google Scholar
Ma X, Ren X, Shen M, Ma F, Chen X, Zhang G, et al. Volumetric ADC histogram analysis for preoperative evaluation of LVSI status in stage I endometrioid adenocarcinoma. Eur Radiol. 2022;32(1):460–9.
Nougaret S, Vargas HA, Lakhman Y, Sudre R, Do RK, Bibeau F, et al. Intravoxel Incoherent Motion-derived Histogram Metrics for Assessment of Response after Combined Chemotherapy and Radiation Therapy in rectal Cancer: initial experience and comparison between single-section and volumetric analyses. Radiology. 2016;280(2):446–54.
Le Bihan D. Molecular diffusion, tissue microdynamics and microstructure. NMR Biomed. 1995;8(7–8):375–86.
Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228–47.
Article CAS PubMed Google Scholar
Zhao DW, Fan WJ, Meng LL, Luo YR, Wei J, Liu K, et al. Comparison of the pre-treatment functional MRI metrics’ efficacy in predicting Locoregionally advanced nasopharyngeal carcinoma response to induction chemotherapy. Cancer Imaging. 2021;21(1):59.
Article PubMed PubMed Central Google Scholar
Surov A, Pech M, Meyer HJ, Bitencourt AGV, Fujimoto H, Baxter GC, et al. Evaluation of pretreatment ADC values as predictors of treatment response to neoadjuvant chemotherapy in patients with breast cancer - a multicenter study. Cancer Imaging. 2022;22(1):68.
Article PubMed PubMed Central Google Scholar
Zhang H, Li W, Fu C, Grimm R, Chen Z, Zhang W, et al. Comparison of intravoxel incoherent motion imaging, diffusion kurtosis imaging, and conventional DWI in predicting the chemotherapeutic response of colorectal liver metastases. Eur J Radiol. 2020;130:109149.
Yuan Z, Niu XM, Liu XM, Fu HC, Xue TJ, Koo CW, et al. Use of diffusion-weighted magnetic resonance imaging (DW-MRI) to predict early response to anti-tumor therapy in advanced non-small cell lung cancer (NSCLC): a comparison of intravoxel incoherent motion-derived parameters and apparent diffusion coefficient. Transl Lung Cancer Res. 2021;10(8):3671–81.
Article CAS PubMed PubMed Central Google Scholar
Li G, Huang R, Zhu M, Du M, Zhu J, Sun Z, et al. Native T1-mapping and diffusion-weighted imaging (DWI) can be used to identify lung cancer pathological types and their correlation with Ki-67 expression. J Thorac Dis. 2022;14(2):443–54.
Article PubMed PubMed Central Google Scholar
Ren H, Ma J, Wang J. Correlation between apparent diffusion coefficient and Ki-67 in different pathological types of lung cancer. Transl Cancer Res. 2021;10(12):5364–71.
Article CAS PubMed PubMed Central Google Scholar
Zheng Y, Huang W, Zhang X, Lu C, Fu C, Li S, et al. A Noninvasive Assessment of Tumor Proliferation in Lung cancer patients using Intravoxel Incoherent Motion magnetic resonance imaging. J Cancer. 2021;12(1):190–7.
留言 (0)